CARLSBAD, Calif., Oct. 9, 2013 /PRNewswire/ -- Life Technologies Corporation (LIFE) today announced that its GlobalFiler™ Express Kit has been approved by the United States Federal Bureau of Investigation for use by laboratories generating DNA profiles for inclusion in the National DNA Index System (NDIS) CODIS Database. NDIS manages the Federal CODIS forensic DNA database, which facilitates the electronic comparison and exchange of DNA profiles between participating local, county, state, and federal law enforcement agencies and forensic laboratories.
The GlobalFiler™ Express Kit is the first NDIS approved, fully validated 6-dye system, which can be utilized for the rapid analysis of forensic DNA samples, delivering sample-to-answer in two hours. Introduced in the fall of 2012, the GlobalFiler™ Express Kit provides the ability to increase the number of genetic markers obtained from forensic samples by more than 30 percent to 24, with a processing time that's five times faster than other solutions currently on the market.
"Obtaining NDIS approval is an important part of Life Technologies' commitment to provide superior rapid DNA technologies to the law enforcement community worldwide," said Nadia Altomare, Vice President and General Manager for Life Technologies Human Identification Business. "The GlobalFiler™ Express Kit has proven to be a transformative solution for forensic labs, because of its speed and power in comparing DNA data, which ultimately leads to solving and preventing more crimes."
"DNA examiners were able to use the GlobalFiler Express Kit to process a known reference sample from the suspect in a fraction of the time. This allowed the laboratory to connect a suspect to forensic evidence of an unknown sexual assault case," said Kris Cano, Forensic Laboratory Manager, Scottsdale Police Department Crime Laboratory. "The GlobalFiler Express Kit is going to be an important tool for law enforcement to ensuring public safety."
To date, 44 countries have now implemented criminal offender DNA database programs with a combined offender sample pool of 40 million and growing. The GlobalFiler™ Express Kit is the only commercially available forensic genotyping kit that contains all markers recommended for inclusion by the CODIS Core Loci Working Group, including all markers commonly used in most international databases.
About Life Technologies
Life Technologies Corporation (NASDAQ: LIFE) is a global biotechnology company that is committed to providing the most innovative products and services to leading customers in the fields of scientific research, genetic analysis and applied sciences. With a presence in more than 180 countries, the company's portfolio of 50,000 end-to-end solutions is secured by more than 5,000 patents and licenses that span the entire biological spectrum -- scientific exploration, molecular diagnostics, 21st century forensics, regenerative medicine and agricultural research. Life Technologies has approximately 10,000 employees and had sales of $3.8 billion in 2012.
Life Technologies' Safe Harbor Statement
This press release includes forward-looking statements about our anticipated results that involve risks and uncertainties. Some of the information contained in this press release, including, but not limited to, statements as to industry trends and Life Technologies' plans, objectives, expectations and strategy for its business, contains forward-looking statements that are subject to risks and uncertainties that could cause actual results or events to differ materially from those expressed or implied by such forward-looking statements. Any statements that are not statements of historical fact are forward-looking statements. When used, the words "believe," "plan," "intend," "anticipate," "target," "estimate," "expect" and the like, and/or future tense or conditional constructions ("will," "may," "could," "should," etc.), or similar expressions, identify certain of these forward-looking statements. Important factors which could cause actual results to differ materially from those in the forward-looking statements are detailed in filings made by Life Technologies with the Securities and Exchange Commission. Life Technologies undertakes no obligation to update or revise any such forward-looking statements to reflect subsequent events or circumstances.
- Life Technologies